(Q38596419)

4 September 2017

1 reference

title

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease (English)

1 reference

4 September 2017

0 references

Thal LJ

1

1 reference

4 September 2017

Masur DM

2

1 reference

4 September 2017

Blau AD

3

1 reference

4 September 2017

Fuld PA

4

1 reference

4 September 2017

Klauber MR

5

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

Journal of the American Geriatrics Society

4 September 2017

1 reference

4 September 2017

37

1 reference

4 September 2017

1

1 reference

4 September 2017

42-48

1 reference

Selective loss of central cholinergic neurons in Alzheimer's disease

4 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Necropsy evidence of central cholinergic deficits in senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Neocortical cholinergic neurons in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer-Type Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Dopamine in Alzheimer's disease and senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Somatostatin content and release measured in cerebral biopsies from demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Brain muscarinic receptors in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Clinical effects of choline in Alzheimer senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Influence of choline on amnesia in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Choline therapy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Choline chloride in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Effects of physostigmine and lecithin on memory in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Physostigmine effects in Alzheimer's disease: relationship to dementia severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Physostigmine and its effect on six patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Vasopressin and physostigmine in the treatment of amnesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Oral physostigmine treatment of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Effects of oral physostigmine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Evaluating storage, retention, and retrieval in disordered memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

The performance test of activities of daily living

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Prevalence and Malignancy of Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Diagnostic Accuracy in Presenile Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Validity of clinical diagnosis in dementia: a prospective clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB01567.X

10.1111/J.1532-5415.1989.TB01567.X

21 January 2018

Identifiers

DOI

1 reference

release_r5bogzh4zjf6lbwqce7j5hnsoi

4 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r5bogzh4zjf6lbwqce7j5hnsoi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference